Which place for avelumab in the management of urothelial carcinoma?

Larroquette, M; Gross-Goupil, M; Daste, A; Robert, G; Ravaud, A; Domblides, C

Gross-Goupil, M (reprint author), Bordeaux Univ Hosp, Dept Med Oncol, Bordeaux, France.

EXPERT OPINION ON BIOLOGICAL THERAPY, 2019; 19 (9): 863